Jean-Michel Halfon
Independent Director
With his years of experience in senior management at leading pharmaceutical companies, particularly his experience with emerging markets, Mr. Halfon provides expertise in international pharmaceutical operations and marketing.
Mr. Halfon joined the Board of Directors in 2014.
He currently serves as an independent consultant, providing consulting services to pharmaceutical, distribution, healthcare IT and R&D companies. From 2008 to 2010, Mr. Halfon served as President and General Manager of Emerging Markets at Pfizer Inc., after serving in various senior management positions since 1989. From 1987 to 1989, Mr. Halfon served as Director of Marketing in France for Merck & Co., Inc.
Mr. Halfon received a B.S. from Ecole Centrale des Arts et Manufactures and an M.B.A. from Institut Supérieur des Affaires.
Dr. Sol J. Barer
Chairman of the Board Independent Director
Kåre Schultz
Director and President and Chief Executive Officer
Rosemary A. Crane
Independent Director
Amir Elstein
Independent Director
Janet S. Vergis
Independent Director
Roberto A. Mignone
Independent Director
Dr. Perry D. Nisen
Independent Director
Nechemia (Chemi) J. Peres
Independent Director
Prof. Ronit Satchi-Fainaro
Independent Director
Gerald M. Lieberman
Independent Director
Abbas Hussain
Independent Director
